OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nanomedicine-Based Therapeutics to Combat Acute Lung Injury
Shuai Bian, Hongfei Cai, Youbin Cui, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 2247-2269
Open Access | Times Cited: 39
Shuai Bian, Hongfei Cai, Youbin Cui, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 2247-2269
Open Access | Times Cited: 39
Showing 1-25 of 39 citing articles:
Hippo signaling pathway and respiratory diseases
Weifeng Tang, Min Li, Xiaoting Yangzhong, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 43
Weifeng Tang, Min Li, Xiaoting Yangzhong, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 43
Targeting ferroptosis using Chinese herbal compounds to treat respiratory diseases
Mengjiao Xu, Di Zhang, Jun Yan
Phytomedicine (2024) Vol. 130, pp. 155738-155738
Open Access | Times Cited: 10
Mengjiao Xu, Di Zhang, Jun Yan
Phytomedicine (2024) Vol. 130, pp. 155738-155738
Open Access | Times Cited: 10
Advances in nanomaterial-targeted treatment of acute lung injury after burns
Shuo Zhang, Xinyu Zhao, Yuhao Xue, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 10
Shuo Zhang, Xinyu Zhao, Yuhao Xue, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 10
Inflammation-targeting nanoparticles impede neutrophil infiltration and scavenge ROS for acute lung injury alleviation
Ling Ma, Fang Chen, Shuang Chen, et al.
International Journal of Pharmaceutics (2025) Vol. 673, pp. 125359-125359
Closed Access | Times Cited: 1
Ling Ma, Fang Chen, Shuang Chen, et al.
International Journal of Pharmaceutics (2025) Vol. 673, pp. 125359-125359
Closed Access | Times Cited: 1
Paving the way for phage therapy using novel drug delivery approaches
Thomas Briot, Camille Kolenda, Tristan Ferry, et al.
Journal of Controlled Release (2022) Vol. 347, pp. 414-424
Open Access | Times Cited: 31
Thomas Briot, Camille Kolenda, Tristan Ferry, et al.
Journal of Controlled Release (2022) Vol. 347, pp. 414-424
Open Access | Times Cited: 31
Metal‐Organic Frameworks Nanocarriers for Functional Nucleic Acid Delivery in Biomedical Applications
He Li, Mengdi Shang, Zhongkai Chen, et al.
The Chemical Record (2023) Vol. 23, Iss. 6
Closed Access | Times Cited: 21
He Li, Mengdi Shang, Zhongkai Chen, et al.
The Chemical Record (2023) Vol. 23, Iss. 6
Closed Access | Times Cited: 21
Delivery systems of therapeutic nucleic acids for the treatment of acute lung injury/acute respiratory distress syndrome
Chuanyu Zhuang, Minji Kang, Minhyung Lee
Journal of Controlled Release (2023) Vol. 360, pp. 1-14
Closed Access | Times Cited: 17
Chuanyu Zhuang, Minji Kang, Minhyung Lee
Journal of Controlled Release (2023) Vol. 360, pp. 1-14
Closed Access | Times Cited: 17
A Review of Non-Invasive Drug Delivery through Respiratory Routes
Yongbo Zhang, Dong Xu, Lu Bai, et al.
Pharmaceutics (2022) Vol. 14, Iss. 9, pp. 1974-1974
Open Access | Times Cited: 27
Yongbo Zhang, Dong Xu, Lu Bai, et al.
Pharmaceutics (2022) Vol. 14, Iss. 9, pp. 1974-1974
Open Access | Times Cited: 27
An mTOR siRNA‐Loaded Spermidine/DNA Tetrahedron Nanoplatform with a Synergistic Anti‐Inflammatory Effect on Acute Lung Injury
Chaowang Huang, Qianyi You, Jing Xu, et al.
Advanced Healthcare Materials (2022) Vol. 11, Iss. 11
Closed Access | Times Cited: 23
Chaowang Huang, Qianyi You, Jing Xu, et al.
Advanced Healthcare Materials (2022) Vol. 11, Iss. 11
Closed Access | Times Cited: 23
Inhalable and bioactive lipid-nanomedicine based on bergapten for targeted acute lung injury therapy via orchestrating macrophage polarization
Ran Liao, Zhichao Sun, Liying Wang, et al.
Bioactive Materials (2024) Vol. 43, pp. 406-422
Closed Access | Times Cited: 5
Ran Liao, Zhichao Sun, Liying Wang, et al.
Bioactive Materials (2024) Vol. 43, pp. 406-422
Closed Access | Times Cited: 5
Farrerol Inhibits Ferroptosis and Protects Against Lps-Induced Acute Lung Injury by Targeting the Uchl3/Runx1/Slc7a11 Axis
Ying Xu, Yueyan Yang, Shihua Deng, et al.
(2025)
Closed Access
Ying Xu, Yueyan Yang, Shihua Deng, et al.
(2025)
Closed Access
Adaptive bilirubin nanoscavenger alleviates pulmonary oxidative stress and inflammation for acute lung injury therapy
Longfa Kou, Yitianhe Xu, Shize Li, et al.
Journal of Advanced Research (2025)
Open Access
Longfa Kou, Yitianhe Xu, Shize Li, et al.
Journal of Advanced Research (2025)
Open Access
Nano‐Enabled Reposition of Proton Pump Inhibitors for TLR Inhibition: Toward A New Targeted Nanotherapy for Acute Lung Injury
Liya Sun, Yuan Liu, Xiali Liu, et al.
Advanced Science (2021) Vol. 9, Iss. 3
Open Access | Times Cited: 29
Liya Sun, Yuan Liu, Xiali Liu, et al.
Advanced Science (2021) Vol. 9, Iss. 3
Open Access | Times Cited: 29
Histopathological, physiological and biochemical assessment of resveratrol nanocapsules efficacy in bleomycin-induced acute and chronic lung injury in rats
Neama M. Albanawany, Doaa M. Samy, Noha Zahran, et al.
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 2592-2608
Open Access | Times Cited: 19
Neama M. Albanawany, Doaa M. Samy, Noha Zahran, et al.
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 2592-2608
Open Access | Times Cited: 19
Length‐Controlled Construction of Ceria Nanowires with Ultrafine Diameter and Stable Morphology for Targeted Acute Lung Injury Therapy
Qingshan Liu, Guangyou Shi, Yang Lü, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 22
Closed Access | Times Cited: 12
Qingshan Liu, Guangyou Shi, Yang Lü, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 22
Closed Access | Times Cited: 12
Botanical characterization, phytochemistry, biosynthesis, pharmacology clinical application, and breeding techniques of the Chinese herbal medicine Fritillaria unibracteata
Yamei Zhang, Hongping Han, Dingai Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Yamei Zhang, Hongping Han, Dingai Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Hexahistidine-metal assembly encapsulated fibroblast growth factor 21 for lipopolysaccharide-induced acute lung injury
Lanlan Song, Huihui Ye, Zhanghang Lv, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2025), pp. 114650-114650
Closed Access
Lanlan Song, Huihui Ye, Zhanghang Lv, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2025), pp. 114650-114650
Closed Access
Lacticaseibacillus rhamnosus CP-1 mitigates LPS-induced acute lung injury in mice via TLR/NF-κB pathway and gut microbiota modulation
J.-S. Lin, Zhonghua Wang, Jiaojiao Han, et al.
Food Bioscience (2025), pp. 106429-106429
Closed Access
J.-S. Lin, Zhonghua Wang, Jiaojiao Han, et al.
Food Bioscience (2025), pp. 106429-106429
Closed Access
Inflammation‐modulating nanoparticles for pneumonia therapy
Wali Muhammad, Zihe Zhai, Shuqin Wang, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2021) Vol. 14, Iss. 2
Closed Access | Times Cited: 25
Wali Muhammad, Zihe Zhai, Shuqin Wang, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2021) Vol. 14, Iss. 2
Closed Access | Times Cited: 25
Sivelestat sodium attenuates acute lung injury by inhibiting JNK/NF-κB and activating Nrf2/HO-1 signaling pathways
Hong Zhang, Jun Zeng, Jiankang Li, et al.
Biomolecules and Biomedicine (2023)
Open Access | Times Cited: 10
Hong Zhang, Jun Zeng, Jiankang Li, et al.
Biomolecules and Biomedicine (2023)
Open Access | Times Cited: 10
High Targeting Specificity toward Pulmonary Inflammation Using Mesenchymal Stem Cell‐Hybrid Nanovehicle for an Efficient Inflammation Intervention
Yuanqin Su, Ting Huang, Hao Sun, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 23
Closed Access | Times Cited: 10
Yuanqin Su, Ting Huang, Hao Sun, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 23
Closed Access | Times Cited: 10
Uncovering the active constituents and mechanisms of Rujin Jiedu powder for ameliorating LPS-induced acute lung injury using network pharmacology and experimental investigations
Yuhui Ma, Hong‐Xi Xu, Gang Chen, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 9
Yuhui Ma, Hong‐Xi Xu, Gang Chen, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 9
Biomedical applications of peptide-gold nanoarchitectonics
Samane Maghsoudian, Esmat Sajjadi, Niloufar Hadavi, et al.
International Journal of Pharmaceutics (2024) Vol. 667, pp. 124920-124920
Closed Access | Times Cited: 3
Samane Maghsoudian, Esmat Sajjadi, Niloufar Hadavi, et al.
International Journal of Pharmaceutics (2024) Vol. 667, pp. 124920-124920
Closed Access | Times Cited: 3
Venetoclax nanomedicine alleviates acute lung injury via increasing neutrophil apoptosis
Ruonan Su, Haixia Wang, Chunsheng Xiao, et al.
Biomaterials Science (2021) Vol. 9, Iss. 13, pp. 4746-4754
Closed Access | Times Cited: 23
Ruonan Su, Haixia Wang, Chunsheng Xiao, et al.
Biomaterials Science (2021) Vol. 9, Iss. 13, pp. 4746-4754
Closed Access | Times Cited: 23
Preventing acute lung injury from progressing to pulmonary fibrosis by maintaining ERS homeostasis through a multistage targeting nanomicelle
Lihua Luo, Zhenyu Luo, Junlei Zhang, et al.
Nano Today (2022) Vol. 48, pp. 101719-101719
Closed Access | Times Cited: 13
Lihua Luo, Zhenyu Luo, Junlei Zhang, et al.
Nano Today (2022) Vol. 48, pp. 101719-101719
Closed Access | Times Cited: 13
